Olivier has served as CEO since the inception of Qynapse in 2015. With 15 years in the pharmaceutical and healthcare industry, he possesses strong entrepreneurship, marketing and management experience – both in the United States and Europe.
Before Qynapse, he served as Director of Strategy and Development for Merck Millipore, a division of Merck KGaA. He joined the Millipore Corp in 2006 to implement pricing practices for a $1 B life science business unit. Earlier on in his career, he co-founded Open Pricer, a company that delivered pricing software to several Fortune 500 companies.
Olivier holds a master’s in business administration from Toulouse Business School and a master’s in technology management from Ecole Centrale Paris.